BioLineRx(BLRX)

财报披露

BioLineRx(BLRX)05-06 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-28 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-24 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-18 05:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-30 19:25

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接查看全文

吕嵩082021-05-04 22:25

$BioLineRx(BLRX)$我日，咋走成这个样子查看全文

魔都弗兰克2021-05-04 21:54

$BioLineRx(BLRX)$卖早了，祝tothe moon查看全文

Linktu2021-05-04 20:07

$BioLineRx(BLRX)$ -研究符合所有主要和次要终点，具有极高的统计显着性（p <0.0001）-
-Motixafortide + G-CSF在最多两次血液采血过程中实现了目标动员的主要终点，与单独的G-CSF相比，增加了4.9倍-
-接受Motixafortide + G-CSF的患者仅进行一次单采血液分离术后就进行了移植，而仅G-C...查看全文

挟韭菜以令诸国2021-05-04 20:05

$BioLineRx(BLRX)$ @冷枪手假亦真 来不来？！查看全文

Linktu2021-05-04 20:01

$BioLineRx(BLRX)$ 呵呵,买对了查看全文

Linktu2021-04-10 00:29

$BioLineRx(BLRX)$ 今天我2.82 买进了一些备着，姑且看看我是否分析买入正确[跪了]查看全文

Linktu2021-03-22 04:14

$BioLineRx(BLRX)$
Motixafortide（BL-8040）查看全文

挟韭菜以令诸国2021-02-23 00:07

$BioLineRx(BLRX)$ 升🚀！查看全文

Linktu2021-02-15 09:59

$BioLineRx(BLRX)$ 又到杀回时查看全文

Linktu2021-02-12 04:40

$BioLineRx(BLRX)$ $BioLineRx(BLRX)$
该公司的牵头计划Motixafortide（BL-8040）是一种癌症治疗平台，目前正在与MSD合作的一项2a期临床试验中评估其与KEYTRUDA®和化学疗法联合治疗胰腺癌。
Motixafortide还在用于自体骨髓移植的干细胞动员的3期研究，r / r AML的2期研究以及针...查看全文

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001347  Act: 34  Size: 612 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001285  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001174  Act: 34  Size: 1 MB 网页链接

招股说明书

$BioLineRx(BLRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001173  Act: 33  Size: 733 KB 网页链接

年度财报「修正」

$BioLineRx(BLRX)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001095  Act: 34  Size: 14 MB 网页链接